Identifiers
Functions
Hazards
Loreal is a key player, claiming azelaic acid's use for increasing cell longevity and treating skin aging via mitochondrial metabolism, and formulating high-concentration emulsions. Niku Co Ltd focuses on particle morphology for powder cosmetics and topical preparations. Other organizations include Vantage Specialty Ingredients (anhydrous concentrates), Fudan University (liquid salts), and Curology (combination therapy kits). Claims span anti-aging, skin brightening, oil control, acne treatment, and hyperpigmentation, with a strong emphasis on solving solubility and irritation through innovative formulation.
Monthly patent filings by domain
Recent patents primarily address azelaic acid's poor water solubility and inherent skin irritation, which limit its formulation and therapeutic appeal. Technical solutions include creating substantially anhydrous concentrates with amidoamines for clear, precipitate-free solutions; developing microemulsions, deep eutectic solvents, and liquid salts to enhance solubility and reduce irritation; and engineering particle morphologies (spherical, plate-like) with controlled sizes for improved dispersibility and stability in high-concentration systems. These approaches aim to enable higher azelaic acid loadings while maintaining product elegance and user tolerability.
Azelaic acid's role is expanding from a traditional anti-acne and skin-brightening active to a multifunctional ingredient for anti-aging and cellular health. Loreal patents claim its use to increase skin cell longevity and combat signs of aging by stimulating mitochondrial metabolism, positioning it as a mitochondrial health agent. Additionally, it is being repositioned in combination therapies for acne and photoaging (Curology) and as a depigmenting agent in stable emulsions with other actives (Laboratorios Vinas). This shift broadens its application from targeted acne treatments to broader skin health and longevity positioning.
Emerging product categories include powder cosmetics, foams, and anhydrous gels, moving beyond traditional creams and lotions. Formulation strategies focus on advanced delivery systems: microemulsions, composite micelles for triggered release, deep eutectic solvents, and liquid salts to improve solubility and reduce irritation. High-concentration emulsions (9-11% azelaic acid) and low-water systems are also being developed to enhance stability and efficacy. Particle engineering (spherical/plate-like, >10 μm) is used for powder cosmetics, while micro-nanocrystalline suspensions target acne sites. These strategies aim to improve bioavailability, stability, and user experience.
Evidence-backed white space exists in combining azelaic acid with probiotics or fermentation products for synergistic oil control and acne treatment, as seen in a Chinese patent using Lactobacillus casei. Another area is the use of azelaic acid in low-water or anhydrous systems for enhanced stability, which could be extended to new product forms. Additionally, the anti-aging claims related to mitochondrial metabolism open opportunities for positioning azelaic acid in longevity-focused skincare, though this is still early-stage. These areas are supported by recent patent filings but lack commercial validation.